EIF4EBP1 and Mobius syndrome: Together with our finding that 4EBP1 protein levels correlate with poor outcome across all MB groups as well as in Group 3/Group 4 MB patients, the available data highlight that EIF4EBP1 mRNA and 4EBP1 protein expression may represent novel prognostic factors and possible biomarkers in MBs.